Date of Award
Fall 12-15-2022
Document Type
Project (696 or 796 registration)
Degree Name
Master of Science in Accounting & Finance
Department
Graduate Studies
Committee Chair
Dr. Mohamed Elnannan
Abstract
This report aims to provide a financial analysis built from qualitative and quantitative data on Surmodics, Inc., a medical device manufacturer headquartered in Eden Prairie. I will discuss how the firm is performing and compare its financial results to a competitor in the industry, Cardiovascular Systems, Inc. Surmodics has been awaiting approval for various new devices, none more important than the SurVeil DCB. The delays in regulatory approval for these products have delayed millions in revenue for Surmodics, and any further delay increases the company’s level of risk. Throughout the various sections of this report, it will become clear that while CSII is the larger company, Surmodics has a better strategy and higher growth potential than Cardiovascular Systems, Inc.
Recommended Citation
Colgrove, Denver, "Financial Analysis of Surmodics, Inc." (2022). Dissertations, Theses, and Projects. 736.
https://red.mnstate.edu/thesis/736